SCHEMBL3931071

SCHEMBL3931071

CN(C=O)C(=O)NC1CCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.44
EPHX1 P07099 7/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MAPT P10636 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP3A4 P08684 1/20 0.40
EPHX2 P34913 1/20 0.40
MMP2 P08253 1/20 0.39
MMP8 P22894 1/20 0.39
LMNA P02545 1/20 0.38
ADH1C P00326 2/20 0.38
ADH1A P07327 2/20 0.38
ADRA2A P08913 1/20 0.38
PDE4A P27815 1/20 0.38
ADRA1A P35348 1/20 0.38
HPGD P15428 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7021364 0.75 CCR5 (0.48) PKMEPHX1NPC1RAB9ASMN1; SMN2
SCHEMBL6624571 0.74 EPHX1 (0.43) PKMEPHX1NPC1RAB9ASMN1; SMN2
SCHEMBL11438411 0.74 PKM (0.53) PKMEPHX1NPC1RAB9ASMN1; SMN2
SCHEMBL7022369 0.73 CCR5 (0.50) PKMEPHX1NPC1RAB9ASMN1; SMN2
SCHEMBL28452777 0.73 EPHX1 (0.47) PKMEPHX1NPC1RAB9ASMN1; SMN2
SCHEMBL9451038 0.72 EPHX1 (0.56) PKMEPHX1NPC1RAB9ASMN1; SMN2
SCHEMBL135838 0.72 EPHX1 (0.56) PKMEPHX1NPC1RAB9ASMN1; SMN2
SCHEMBL11608613 0.72 EPHX1 (0.56) PKMEPHX1NPC1RAB9ASMN1; SMN2
SCHEMBL2869853 0.72 EPHX1 (0.56) PKMEPHX1NPC1RAB9ASMN1; SMN2
SCHEMBL679618 0.72 CCR5 (0.52) PKMEPHX1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049536-A2 POLYCYCLIC VIRAL INHIBITORS GENELABS TECHNOLOGIES, INC. (US) 2009-04-22 EP disclosed
EP-2044083-A1 ANTIVIRAL AGENTS GENELABS TECHNOLOGIES, INC. (US) 2009-04-08 EP disclosed
WO-2008011521-A2 POLYCYCLIC VIRAL INHIBITORS GENELABS TECHNOLOGIES, INC. (US) 2008-01-24 WO disclosed
WO-2008008907-A2 ANTIVIRAL AGENTS GENELABS TECHNOLOGIES, INC. (US) 2008-01-17 WO disclosed
WO-2008008912-A1 ANTIVIRAL AGENTS GENELABS TECHNOLOGIES, INC. (US) 2008-01-17 WO disclosed